Healthcare Professionals

The therapeutic effectiveness of Anusol™ has been demonstrated, time and time again, over more than 85 years of clinical, and home, use.

And, since it was launched in the UK its current pharmaceutical formulation back in 1932, Anusol™ remains a unique product to this day.

Anusol™ formula contains an astringent to help soothe the area and reduce swelling; an antiseptic to reduce the risk of infection; an emollient to help protect sore skin; and a topical corticosteroid to reduce inflammation, redness and itching.

With multiple products formats (including creams, ointments and suppositories) across all pharmaceutical categories (GSL, P, POM) the Anusol™ portfolio strategically covers all therapeutic needs, consumer preferences and commercial channels.